4//SEC Filing
HAUMANN BRETT K 4
Accession 0001179110-19-002409
CIK 0001583107other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:13 PM ET
Size
4.4 KB
Accession
0001179110-19-002409
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2019-02-20$27.00/sh−7,778$210,006→ 239,383 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 6:13 PM ET
- Size
- 4.4 KB